VentureBeat October 22, 2024
Even as enterprises across sectors explore how to integrate generative AI, it’s clear that biomedical research and the sciences are among the areas that could benefit most — as highlighted in the recent Nobel Prizes in Chemistry and Physics awarded to AI researchers.
Now Dotmatics, a leader in research and development scientific software, wants to give drug researchers the power of AI to speed up their development of new, life-saving and improving drugs.
Today, the Boston-based company launches Geneious Luma, a powerful new bioinformatics solution for antibody discovery, built on its Luma Scientific Intelligence Platform.
Geneious Luma is designed to streamline the process of biologic therapeutic discovery by integrating advanced sequence analysis, data management, and AI-powered automation. This release marks...
Today's Sponsors
Today's Sponsor